Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > They didn't announce the IND's for oncology and NASH

<< Previous

Bullboard Posts

Next >>

Comment by Lee430on Apr 28, 2023 12:18pm

48 Views

Post# 35419388

RE:RE:RE:RE:They didn't announce the IND's for oncology and NASH

Guessing this means since they hired a proxy solicitor that they've been following this board and are a little concerned of the push for some changes... I kind of like SPCO's idea of withholding votes, however, I feel more comfortable voting them all negative at this time since they don't seem to be getting the message from last year that changes needs to happen NOW!

<< Previous

Bullboard Posts

Next >>

Ivanhoe Mines initiates Phase 3 concentrator construction